Maximizing effectiveness of substances used to improve health and well being
April 2, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesHigh calorie solutions of low molecular weight glucose polymer mixtures useful for intravenous administration Blood glucose control apparatus and method Medication compliance packaging system and procedure Medicament package for increasing compliance with complex therapeutic regimens Delivery device for orally administered therapeutic agents Method and apparatus for pulsed iontophoretic drug delivery System and method for monitoring patient's compliance Multi-vitamin and mineral supplement for pregnant women Compositions and methods for the treatment of the metabolically impaired and for improved compliance 5547878 InventorAssigneeApplicationNo. 053487 filed on 04/02/1998US Classes:424/464, Tablets, lozenges, or pills424/422, Implant or insert424/423, Surgical implant or material424/430, Vaginal, urethral, uterine424/433, Depot, pellet, matrix, or suppository424/434, Mucosal (e.g., nasal, etc.)424/436, Anal, rectal (e.g., suppositories, etc.)424/441, Chewable tablet or wafer424/443, Web, sheet or filament bases; compositions of bandages; or dressings with incorporated medicaments424/451, Capsules (e.g., of gelatin, of chocolate, etc.)424/455, Containing emulsions, dispersions, or solutions424/456, Gelatin424/458, Containing discrete coated particles pellets, granules, or beads424/463, Coated capsules424/468, Sustained or differential release type424/472, Layered unitary dosage forms424/474, Coated pills or tablets424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)424/490, Coated (e.g., microcapsules)514/937DISPERSION OR EMULSIONExaminersPrimary: Page, Thurman K.Assistant: Spear, James M. Attorney, Agent or FirmInternational ClassesA61K 009/14A61K 009/28 A61K 009/48 A61K 009/52 A61K 009/02 A61K 009/06 A61K 009/08 A61K 009/10 490 AbstractThe present disclosure relates to novel dosage forms, drug delivery regimens, methods and pharmaceutical compositions which optimize the therapeutic effects of active therapeutic substances through the application of the concept of uneven dosing.Other References
Field of SearchImplant or insertDepot, pellet, matrix, or suppository Anal, rectal (e.g., suppositories, etc.) Chewable tablet or wafer Web, sheet or filament bases; compositions of bandages; or dressings with incorporated medicaments Capsules (e.g., of gelatin, of chocolate, etc.) Containing emulsions, dispersions, or solutions Gelatin Sustained or differential release Tablets, lozenges, or pills Sustained or differential release type Layered unitary dosage forms Particulate form (e.g., powders, granules, beads, microcapsules, and pellets) Surgical implant or material Vaginal, urethral, uterine Mucosal (e.g., nasal, etc.) Containing discrete coated particles pellets, granules, or beads Coated capsules Coated pills or tablets DISPERSION OR EMULSION | |
